167 related articles for article (PubMed ID: 329858)
21. Borderline hyperprolactinemia in infertile women: evaluation of the prolactin response to thyrotropin releasing hormone and double-blind placebo-controlled treatment with bromocriptine.
Glazener CM; Kelly NJ; Hull MG
Gynecol Endocrinol; 1987 Dec; 1(4):373-8. PubMed ID: 3140587
[TBL] [Abstract][Full Text] [Related]
22. Bromocriptine (Bromergon, Lek) in the management of premenstrual syndrome.
Meden-Vrtovec H; Vujić D
Clin Exp Obstet Gynecol; 1992; 19(4):242-8. PubMed ID: 1294345
[TBL] [Abstract][Full Text] [Related]
23. The psychobiology of premenstrual dysphoria: the role of prolactin.
Carroll BJ; Steiner M
Psychoneuroendocrinology; 1978 Apr; 3(2):171-80. PubMed ID: 568295
[No Abstract] [Full Text] [Related]
24. [Therapy of the premenstrual syndrome and especially of cyclic mastodynia with bromocriptine].
Hauser GA
Ther Umsch; 1983 Jul; 40(7):604-9. PubMed ID: 6684802
[No Abstract] [Full Text] [Related]
25. A double-blind, placebo-controlled evaluation of spironolactone in the premenstrual syndrome.
Vellacott ID; Shroff NE; Pearce MY; Stratford ME; Akbar FA
Curr Med Res Opin; 1987; 10(7):450-6. PubMed ID: 3621990
[TBL] [Abstract][Full Text] [Related]
26. Premenstrual syndrome: a double-blind controlled trial of progesterone and placebo.
Sampson GA
Br J Psychiatry; 1979 Sep; 135():209-15. PubMed ID: 385093
[TBL] [Abstract][Full Text] [Related]
27. Effect of bromocriptine and chlorotrianisene on inhibition of lactation and serum prolactin. A comparative double-blind study.
Utian WH; Begg G; Vinik AI; Paul M; Shuman L
Br J Obstet Gynaecol; 1975 Sep; 82(9):755-9. PubMed ID: 1101946
[TBL] [Abstract][Full Text] [Related]
28. Premenstrual syndrome and spironolactone.
Burnet RB; Radden HS; Easterbrook EG; McKinnon RA
Aust N Z J Obstet Gynaecol; 1991 Nov; 31(4):366-8. PubMed ID: 1799355
[TBL] [Abstract][Full Text] [Related]
29. A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome.
Freeman EW; Rickels K; Sondheimer SJ; Polansky M
JAMA; 1995 Jul; 274(1):51-7. PubMed ID: 7791258
[TBL] [Abstract][Full Text] [Related]
30. Premenstrual syndrome in Cape Town. Part II. A double-blind placebo-controlled study of the efficacy of mefenamic acid.
Gunston KD
S Afr Med J; 1986 Aug; 70(3):159-60. PubMed ID: 3526590
[TBL] [Abstract][Full Text] [Related]
31. A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptine in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level.
Parsanezhad ME; Alborzi S; Jahromi BN
Int J Fertil Womens Med; 2002; 47(6):272-7. PubMed ID: 12570169
[TBL] [Abstract][Full Text] [Related]
32. Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group.
Thys-Jacobs S; Starkey P; Bernstein D; Tian J
Am J Obstet Gynecol; 1998 Aug; 179(2):444-52. PubMed ID: 9731851
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of depot leuprolide in premenstrual syndrome: effect of symptom severity and type in a controlled trial.
Brown CS; Ling FW; Andersen RN; Farmer RG; Arheart KL
Obstet Gynecol; 1994 Nov; 84(5):779-86. PubMed ID: 7936512
[TBL] [Abstract][Full Text] [Related]
34. A double-blind placebo-controlled trial of progesterone vaginal suppositories in the treatment of premenstrual syndrome.
Maddocks S; Hahn P; Moller F; Reid RL
Am J Obstet Gynecol; 1986 Mar; 154(3):573-81. PubMed ID: 3513587
[TBL] [Abstract][Full Text] [Related]
35. Induced anovulation as treatment of premenstrual tension syndrome. A double-blind cross-over study with GnRH-agonist versus placebo.
Hammarbäck S; Bäckström T
Acta Obstet Gynecol Scand; 1988; 67(2):159-66. PubMed ID: 3140572
[TBL] [Abstract][Full Text] [Related]
36. A double blind controlled study of the hormonal and clinical effects of bromocriptine in the polycystic ovary syndrome.
Buvat J; Buvat-Herbaut M; Marcolin G; Racadot A; Fourlinnie JC; Beuscart R; Fossati P
J Clin Endocrinol Metab; 1986 Jul; 63(1):119-24. PubMed ID: 3519644
[TBL] [Abstract][Full Text] [Related]
37. Hyperprolactinaemia and luteal insufficiency.
Seppälä M; Ranta T; Hirvonen E
Lancet; 1976 Jan; 1(7953):229-30. PubMed ID: 55535
[TBL] [Abstract][Full Text] [Related]
38. Estradiol in premenstrual asthma: a double-blind, randomized, placebo-controlled, crossover study.
Ensom MH; Chong G; Zhou D; Beaudin B; Shalansky S; Bai TR
Pharmacotherapy; 2003 May; 23(5):561-71. PubMed ID: 12741429
[TBL] [Abstract][Full Text] [Related]
39. New hyperprolactinemia and anovulation model in common marmoset (Callithrix jacchus) and effect of cabergoline.
Moro M; Inada Y; Kojima M; Miyata H; Komatsu H; Torii R
Eur J Pharmacol; 1999 Feb; 368(1):57-66. PubMed ID: 10096770
[TBL] [Abstract][Full Text] [Related]
40. Treatment of premenstrual syndrome by spironolactone.
O'Brien PM; Craven D; Selby C; Symonds EM
Br J Obstet Gynaecol; 1979 Feb; 86(2):142-7. PubMed ID: 371663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
